Fresenius reported EUR5.88B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Akzo Nobel EUR 2.54B 52M Sep/2026
Alcon AG USD 2.72B 60M Sep/2026
AstraZeneca USD 16.21B 830M Sep/2026
BASF EUR 16.36B 850M Sep/2026
Bayer EUR 10.05B 820M Sep/2026
Beiersdorf EUR 2.4B 50M Sep/2026
DaVita Healthcare Partners USD 3.58B 30M Sep/2026
Demant DKK 6.67B 420M Jun/2026
E.ON EUR 16.96B 710M Sep/2026
Essilor EUR 14.82B 351M Jun/2026
Fresenius EUR 5.88B 70M Sep/2026
Fresenius Medical Care EUR 4.94B 80M Sep/2026
Getinge SEK 8.38B 1000K Jun/2026
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 8.89B 480M Sep/2026
GN Store Nord DKK 2.27B 100M Sep/2026
GRIFOLS EUR 2.04B 170M Sep/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.63B 200M Sep/2026
Novartis USD 14.52B 112M Sep/2026
Philips EUR 4.4B 40M Sep/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
RWE EUR 4.7B 1.35B Sep/2026
Sanofi EUR 14.44B 2.49B Sep/2026
Smith & Nephew USD 1.6B 1.58B Jun/2026